J&J shares fall but $8 billion jury award likely to be slashed

Johnson & Johnson shares were off more than 2% on Wednesday, a day after a U.S. jury said it must pay $8 billion in punitive damages to a plaintiff in a case involving its anti-psychotic drug Risperdal, a penalty the company and others are confident will not stand.

Read more: http://feeds.reuters.com/~r/reuters/topN...